This is a preview of subscription content, log in via an institution to check access.
Reference
de Bock GH, et al. Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness. British Journal of Cancer : 11 Apr 2013. Available from: URL: http://dx.doi.org/10.1038/bjc.2013.149
Additional information
* annual mammography and MRI for women aged 25 years for life
** annual mammography and MRI for women aged 30–50 years and mammography alone every 3 years for those aged 50–70 years
Rights and permissions
About this article
Cite this article
Breast cancer screening strategies for high-risk women evaluated. PharmacoEcon Outcomes News 677, 4 (2013). https://doi.org/10.1007/s40274-013-0347-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0347-0